Sanofi India Limited has informed the Exchange about Resignation of Senior Management Personnel of the Company
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India has informed the stock exchanges that Ms. Yasmin Shenoy, Head of Regulatory Affairs for India, Nepal, Sri Lanka, and Maldives, has resigned from her position. Her resignation is due to personal commitments and a desire to pursue a new career direction, as mentioned in her resignation letter. She will be relieved from services effective 1st August 2025, with the letter formally submitted on 6th May 2025. She has committed to ensuring a smooth transition, including training her replacement and wrapping up pending projects. The company has filed the required disclosures under SEBI's Listing Regulations.
This is a mid-level senior management departure, not involving the CEO, CFO, or board. For shareholders, the impact is likely limited, though regulatory affairs leadership is important in a pharma company, and any prolonged vacancy could affect ongoing compliance work. No immediate stock price impact is expected.